Todo sobre la candidata a vacuna COVID-19 de Pfizer y su posible eficacia en un 90%
La vacuna candidata de Pfizer y BioNTech es parte del grupo de vacunas genéticas, que usan uno o más genes del coronavirus, en este caso el SARS-CoV-2, para provocar una respuesta inmune.
- 9 de noviembre de 2020 10:44 p.m.
:quality(75)/cdn.jwplayer.com/v2/media/XS7tEYWM/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/zT4jw3DA/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/OzRIAg1X/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/i3jOYWS9/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/dEZ1NmW9/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/gRqhWGU1/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/nEvEXqJ1/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/MdMLyqyf/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/oQ8Zi6Is/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/ZCtetEhh/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/keAG33b4/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/68PW3Z85/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Z7is1OKJ/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/aofYlF2O/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/hZsFYmlD/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/F5QznZ89/poster.jpg)